ArticlebioRxiv : the preprint server for biology2026
Cytoskeletal disassembly by optogenetic control of RhoA signaling termination.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cellular morphodynamics require adaptive cytoskeletal remodeling, mediated by precisely coordinated activation and termination of RhoA GTPase signaling. RhoA activation is well-studied, but the kinetics and molecular basis of signaling termination remain poorly understood. We engineered an optogenetic toolbox on the single-component BcLOV4 platform for bidirectional control of RhoA activation (opto-GEF11) and termination (opto-DLC1). Prior studies have inferred GTPase inactivation kinetics indirectly, by tracking passive recovery from an activated state, but whether this reflects the kinetics of forward signaling termination remains unclear. Using opto-DLC1, we show that direct RhoA termination is an order of magnitude faster than passive disactivation, despite comparable signaling amplitude. Mechanistically, opto-DLC1 triggered rapid actin disassembly through cofilin disinhibition but drove YAP nuclear efflux at half the rate of opto-GEF11-induced nuclear influx. Together, these findings introduce a platform technology for controlling protein signaling termination, resolve RhoA activation and termination kinetics with sub-second precision, and reveal a mechanistic asymmetry between signaling activation and termination that enables cytoskeletal homeostasis.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.